Atrovent HFA Related Clinical Trials
Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT� Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes [Completed]
Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients [Completed]
Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease [Completed]
Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease [Completed]
Comparison of Tiotropium Inhalation Capsules and Atrovent Metered Dose Inhaler (MDI) in a Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease [Completed]
PT001 MDI Versus Atrovent Study in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Completed]
A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation [Completed]
Budesonide Inhalation Suspension for Acute Asthma in Children [Completed]
Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease [Completed]
Comparative Pharmacokinetics and Pharmacodynamics of Tiotropium With Ipratropium or Placebo After 19 Days of Tiotropium Treatment [Completed]
A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium [Completed]
Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease [Completed]
Postmarketing Surveillance Study of Atrovent® in Chronic Obstructive Airways Disease [Completed]
Post-marketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease [Completed]
Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease [Completed]
Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease [Completed]
Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease [Completed]
Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease [Completed]
Postmarketing Surveillance Study of Atrovent® Inhalation Solution in Chronic Obstructive Pulmonary Disease [Completed]
Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD [Completed]
Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Duration of Protective Effect From Inhaled Ipratropium Bromide on Methacholine Airway Hyperresponsiveness [Completed]
Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy [Completed]
Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Ipratropium Bromide in Peri-Operative COPD [Active, not recruiting]
An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs. [Completed]
A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD) [Completed]
The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia [Completed]
Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease [Completed]
Pharmacogenetics of b2-Agonists in Asthma. [Completed]
Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children [Terminated]
Actuation Indicator Trial in Patients With COPD [Completed]
Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease [Completed]
Optimising the Propranolol Block Model [Completed]
A Crossover Study in the Treatment of Patients With COPD [Completed]
Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children [Not yet recruiting]
Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment [Completed]
Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction [Completed]
Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia [Completed]
Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm [Completed]
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population [Completed]
Postmarketing Surveillance Study of Anticholinergics - Prescribing Pattern and Therapeutic Long Term Value in Patients Suffering From Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM) [Completed]
Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017 [Recruiting]
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room [Completed]
HandiHaler® vs. Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Risk of Re-Hospitalization in Patients With Chronic Obstructive Pulmonary Disease (COPD) Post Exacerbation [Completed]
Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies [Completed]
GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease [Recruiting]
An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients [Recruiting]
Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients [Completed]
Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma [Completed]
Nebulized Magnesium Sulfate in Pediatric Asthma [Terminated]
A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD [Completed]
Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent� Inhalation Aerosol in COPD Patients. [Completed]
Ventilator Adapters for Combivent Respimat [Completed]
Prevention of Lung Edema After Thoracic Surgery [Completed]
Lung Health Study (LHS) I and III [Completed]
Effect of Nebulized Bronchodilators on Heart Rate [Completed]
A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients. [Completed]
Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects [Completed]
A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD [Terminated]
High-resolution Computed Tomography (HRCT) Evaluation of Airway Distensibility in Lung Transplant Recipients [Recruiting]
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate [Completed]
Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Terminated]
Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation [Completed]
A Study in Patients With Chronic Obstructive Pulmonary Disease (FAIR) [Terminated]
Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma [Terminated]
WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction [Completed]
Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) [Completed]
Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD [Not yet recruiting]
Berodual� Respimat� vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease [Terminated]
Radioaerosol Pulmonary Deposition During Asthma Exacerbation Through Noninvasive Ventilation [Completed]
A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients [Terminated]
A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
COPD AND ASSESSMENT OF RADIOLABELED AEROSOL DURING NONINVASIVE VENTILATION [Completed]
Asthma and Quantifying Delivery Of Radio Labeled Aerosol [Completed]
Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition [Completed]
Radioaerossol Pulmonary Deposition Using Mesh in Normal Subjects [Completed]
A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Completed]
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD [Completed]
Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) [Completed]
Magnesium Nebulization Utilization in Management of Pediatric Asthma [Recruiting]
Plethysmography Opto-electronic and Asthma [Completed]
Hemodynamics and Extravascular Lung Water in Acute Lung Injury [Completed]
|
